Skip to content

Clinical study of changes in lung and gut microbiome in patients with ARDS

Clinical study of changes in lung and gut microbiome in patients with ARDS

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400085728
Enrollment
Unknown
Registered
2024-06-17
Start date
2024-06-20
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ARDS

Interventions

Observation group:None

Sponsors

Zhongda Hospital, Affiliated to Southeast University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age: 18 to 85 years 2. Meet the 2012 Berlin Diagnostic Criteria for ARDS. 3. invasive mechanical ventilation for no more than 24 hours during ICU admission 4. expected survival time in the ICU is >24 hours

Exclusion criteria

Exclusion criteria: 1. patients with chronic lung diseases (COPD/asthma/pulmonary fibrosis/bronchiectasis/old tuberculosis, etc.) 2. pregnant women 3. patients with malignant tumours 4. patients with immune system disorders 5. patients with high risk of fibreoptic bronchoscopy (pneumothorax/active bronchospasm/severe acidosis PH<7.2/systolic blood pressure <90mmHg on vasoactive drug support/coagulation abnormality with bleeding tendency/unstable cardiac arrhythmia/increased intracranial pressure, etc.) 6. patients with severe intestinal obstruction unable to obtain faeces

Design outcomes

Primary

MeasureTime frame
ASV;28 day mortality rate;

Secondary

MeasureTime frame
Prognostic indicators;

Countries

China

Contacts

Public ContactGuo Fengmei

Zhongda Hospital Affiliated to Southeast University

1147030162@qq.com+86 138 1384 1261

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026